INTERNATIONAL PATENT: NOBO MEDICINE INC., (주)노보메디슨, HANMI PHARM. CO., LTD., 한미약품 주식회사 FILES APPLICATION FOR "COMBINATION ADMINISTRATION THERAPY OF POSELTINIB FOR PREVENTING OR TREATING LYMPHOMA"

Posted On: 2025-12-10

GENEVA, Dec. 10 -- NOBO MEDICINE INC. (720-ho, 721-ho, 722-ho, 1-dong, 48, Achasan-ro 17-gil,Seongdong-gu,Seoul 04799), (주)노보메디슨 (서울특별시성동구아차산로17길 48, 1동 720호, 721호, 722호), HANMI PHARM. CO., LTD. (214, Muha-ro, Paltan-myeon,Hwaseong-si,Gyeonggi-do 18536), 한미약품 주식회사 (경기도화성시팔탄면 무하로 214) filed a patent application (PCT/KR2025/007588) for "COMBINATION ADMINISTRATION THERAPY OF POSELTINIB FOR PREVENTING OR TREATING LYMPHOMA" on Jun 02, 2025. With publ...

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

INTERNATIONAL PATENT: NOBO MEDICINE INC., (주)노보메디슨, HANMI PHARM. CO., LTD., 한미약품 주식회사 FILES APPLICATION FOR "COMBINATION ADMINISTRATION THERAPY OF POSELTINIB FOR PREVENTING OR TREATING LYMPHOMA"